Showing results (1551-1560 of 2,367) with videos related to

Sort By:
Pageof 237
Future Medicinal Chemistry|August 10, 2017
Molecular modeling, enzyme activity, anti-inflammatory and antiarthritic activities of newly synthesized quinazoline derivativesHatem A Abuelizz, Anouar El Hassane, Mohamed Marzouk, et al.
Future Medicinal Chemistry|August 11, 2017
A novel series of N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amines as highly potent CDK4/6 inhibitorsSolomon Tadesse, Ge Zhu, Laychiluh B Mekonnen, et al.
Future Medicinal Chemistry|October 28, 2017
Activity of gallic acid and its ester derivatives in Caenorhabditis elegans and zebrafish (Danio rerio) modelsJunya de Lacorte Singulani, Liliana Scorzoni, Paulo César Gomes, et al.
Future Medicinal Chemistry|October 28, 2017
CDK5 in oncology: recent advances and future prospectsJimma Likisa Lenjisa, Solomon Tadesse, Nishat Zareen Khair, et al.
Future Medicinal Chemistry|October 28, 2017
New insights for the use of quercetin analogs in cancer treatmentDomenico Iacopetta, Fedora Grande, Anna Caruso, et al.
Future Medicinal Chemistry|August 26, 2017
Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancersElla Lineham, John Spencer, Simon J Morley
Future Medicinal Chemistry|September 9, 2017
A fruitful decade for fungal polyketides from 2007 to 2016: antimicrobial activity, chemotaxonomy and chemodiversityHidayat Hussain, Abdullah M Al-Sadi, Barbara Schulz, et al.
Future Medicinal Chemistry|September 5, 2017
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agentsMaria Dichiara, Emanuele Amata, Antonio Rescifina, et al.
Future Medicinal Chemistry|August 24, 2017
Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?Maria I Cruz, Honorina Cidade, Madalena Pinto
Future Medicinal Chemistry|December 15, 2015
Discovery of novel FFA4 (GPR120) receptor agonists with β-arrestin2-biased characteristicsAng Li, Duxiao Yang, Mengyuan Zhu, et al.
Pageof 237